Dr. Mohammed Al-Hijji
Scope of Practice
- Coronary artery disease management and minimal invasive intervention
- Coronary physiology and microvascular dysfunction management and intervention
- Hypertrophic cardiomyopathy management and mini-invasive intervention
- Structural heart disease management and mini-invasive intervention
- Valvular heart disease management and mini-invasive intervention
Highlights
Academic Achievements
45
Publications
25
Case Reports
8
Honors & Awards
Health Care Profession Achievements
- Associate Editor of European Heart Journal -Case Reports and local editor of Heart Views Journal; peer reviewer of multiple journals such as Mayo Clinic Proceedings, American Heart Journal, Cardiovascular Catheterization and Interventions Journal, and International Journal of Cardiology
- Level 5 Qualifications in Leadership, ILM 5, Doha, Qatar
- +10 Years of Experience
Experience & Education
- Assistant Professor in Medicine, Weill Cornell Medical College In Qatar
- Assistant Professor in Medicine, College of Medicine, Mayo Clinic, Rochester, MN
- Consultant Interventional and Structural Cardiology, Heart Hospital, Doha, Qatar
- Advanced Interventions in Structural Heart Disease Fellow, College of Medicine, Mayo Clinic, Rochester, MN
- Interventional Cardiology Fellow, College of Medicine, Mayo Clinic, Rochester, MN
- General Cardiology Fellow, College of Medicine, Mayo Clinic, Rochester, MN
- Internal Medicine Resident, Johns Hopkins University Hospital, Baltimore
- Doctor of Medicine (MD), Weill Cornell Medical College in Doha, Qatar
Certifications
- American Board of Interventional Cardiology
- American Board of Internal Medicine
- Cardiovascular Disease National Board of Echocardiography
- Master in Science Certificate, Mayo Clinic, Rochester, MN
- Member of the Society for Cardiovascular Angiography and Interventions -FSCAI
- American College of Cardiology -Fellow (FACC)
- Member of the American Heart Association
- Member of the European Society of Cardiology
- Member of the American Society of Echocardiography
Publications
- 37. Al-Hijji MA, ElHajj S, El Sabbagh A, Alkhouli MA, Crestanello J, Eleid MF, Rihal C, Guerrero M. Temporal outcomes of transcatheter mitral valve replacement in native mitral valve disease with annular calcification. Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29515. Epub ahead of print. PMID: 33539045
- Pierre K, Adedinsewo DA, Al-Hijji M, Miranda WR, Alkhouli M, Eleid MF, Guerrero M, Pollak PM, Rihal CS, El Sabbagh A. 30-day patient reported outcomes can be predicted by change in left atrial pressure and not change in transmitral gradient following MitraClip. Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29477. Epub ahead of print. PMID: 33502087
- Al-Hijji MA, Osman M, Kawsara A, Patel B, Alkhouli M. Comparative Outcomes of Mitral Valve in Valve Implantation Versus Redo Mitral Valve Replacement for Degenerated Bioprotheses. Am J Cardiol. 2020 Oct 1;132:175-176. doi: 10.1016/j.amjcard.2020.06.064. Epub 2020 Jul 3
- Arabi A, Alqahtani A, Arafa S, Altamimi O, Altamimi H, Jalala SA, Rafie IM, Ali MT, Hamid T, Al-Hijji M, Alkhani M, Al-Balushi S, Al Suwaidi J. The Impact of SARS- CoV-2 on ST-Elevation Myocardial Infarction Volume, Time to Presentation, and Door-to-Balloon Time: A Report from a High-Volume Statewide Primary Percutaneous Intervention Program. Heart Views. 2020 Jul-Sep;21(3):161-165. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_159_20. Epub 2020 Oct 13
- Franchi F, Olthoff M, Krier J, Noble C, Al-Hijji M, Ramaswamy V, Witt T, Burke M, Benscoter M, Lerman A, Sandhu GS, Rodriguez-Porcel M. A Metabolic Intravascular Platform to Study FDG Uptake in Vascular Injury.Cardiovasc Eng Technol. 2020 Jan 30